Old Well Partners, LLC Bei Gene, Ltd. Transaction History

Old Well Partners, LLC

$87 Million
Q2 2024

A detailed history of Old Well Partners, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Old Well Partners, LLC holds 10,438 shares of BGNE stock, worth $2.13 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares

10,438

Previous 18,038 42.13%

Holding current value

$2.13 Million

Previous $2.82 Million 47.2%

% of portfolio

1.71%

Previous 2.57%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$129.52 - $174.32 $984,352 - $1.32 Million	-7,600 Reduced 42.13%	10,438 $1.49 Million
Q1 2024 Aug 19, 2024	BUY	$141.8 - $181.47 $1.19 Million - $1.52 Million	8,400 Added 87.16%	18,038 $2.82 Million
Q1 2024 May 15, 2024	BUY	$141.8 - $181.47 $1.19 Million - $1.52 Million	8,400 Added 87.16%	18,038 $2.82 Million
Q4 2023 Aug 19, 2024	SELL	$158.67 - $201.58 $1.51 Million - $1.92 Million	-9,527 Reduced 49.71%	9,638 $1.74 Million
Q4 2023 Feb 14, 2024	SELL	$158.67 - $201.58 $1.51 Million - $1.92 Million	-9,527 Reduced 49.71%	9,638 $1.74 Million
Q3 2023 Aug 19, 2024	SELL	$179.87 - $225.13 $3.71 Million - $4.64 Million	-20,600 Reduced 51.8%	19,165 $3.45 Million
Q3 2023 Nov 14, 2023	SELL	$179.87 - $225.13 $269,805 - $337,695	-1,500 Reduced 7.26%	19,165 $3.45 Million
Q2 2023 Aug 14, 2023	SELL	$178.3 - $266.78 $3.41 Million - $5.1 Million	-19,100 Reduced 48.03%	20,665 $3.68 Million
Q1 2023 Aug 19, 2024	BUY	$215.53 - $274.5 $6.32 Million - $8.05 Million	29,327 Added 280.96%	39,765 $8.57 Million
Q1 2023 May 15, 2023	SELL	$215.53 - $274.5 $581,931 - $741,150	-2,700 Reduced 6.36%	39,765 $8.57 Million
Q4 2022 Feb 14, 2023	BUY	$125.51 - $229.3 $577,346 - $1.05 Million	4,600 Added 12.15%	42,465 $9.34 Million
Q2 2022 Aug 15, 2022	BUY	$121.11 - $216.05 $653,994 - $1.17 Million	5,400 Added 16.63%	37,865 $6.13 Million
Q1 2022 May 16, 2022	BUY	$146.52 - $269.56 $395,604 - $727,812	2,700 Added 9.07%	32,465 $6.12 Million
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $1.57 Million - $2.45 Million	-6,300 Reduced 17.47%	29,765 $8.06 Million
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $873,600 - $1.41 Million	3,500 Added 10.75%	36,065 $13.1 Million
Q2 2021 Aug 16, 2021	SELL	$292.75 - $367.01 $204,925 - $256,907	-700 Reduced 2.1%	32,565 $11.2 Million
Q1 2021 May 17, 2021	SELL	$260.64 - $382.12 $3.46 Million - $5.08 Million	-13,288 Reduced 28.54%	33,265 $11.6 Million
Q4 2020 Feb 18, 2021	BUY	$221.31 - $316.61 $10.3 Million - $14.7 Million	46,553 New	46,553 $12 Million

Others Institutions Holding BGNE

# of Institutions

217

Shares Held

42.1M

Call Options Held

106K

Put Options Held

93.1K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $21.2B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Well Partners, LLC with notifications on news.

Account

Old Well Partners, LLC Bei Gene, Ltd. Transaction History